1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze Heng; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David J.; Fradet, Yves; Lee, Jae Lyun; Fo... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma. (1st September 2020) Authors: Bensimon, Arielle G.; Zhong, Yichen; Swami, Umang; Briggs, Allison; Young, Joshua; Feng, Yuan; Song, Yan; Signorovitch, James; Adejoro, Oluwakayode; Chakravarty, Abhiroop; Chen, Mei; Perini, Rodolfo F.; Geynisman, Daniel M. Journal: Current medical research and opinion Issue: Volume 36:Number 9(2020) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma. Issue 9 (20th March 2021) Authors: McDermott, David F.; Lee, Jae-Lyun; Bjarnason, Georg A.; Larkin, James M. G.; Gafanov, Rustem A.; Kochenderfer, Mark D.; Jensen, Niels Viggo; Donskov, Frede; Malik, Jahangeer; Poprach, Alexandr; Tykodi, Scott S.; Alonso-Gordoa, Teresa; Cho, Daniel C.; Geertsen, Poul F.; Climent Duran, Miguel Ange... Journal: Journal of clinical oncology Issue: Volume 39:Issue 9(2021) Page Start: 1020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma. Issue 9 (20th March 2021) Authors: McDermott, David F.; Lee, Jae-Lyun; Ziobro, Marek; Suarez, Cristina; Langiewicz, Przemyslaw; Matveev, Vsevolod Borisovich; Wiechno, Pawel; Gafanov, Rustem Airatovich; Tomczak, Piotr; Pouliot, Frederic; Donskov, Frede; Alekseev, Boris Yakovlevich; Shin, Sang Joon; Bjarnason, Georg A.; Castellano, ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 9(2021) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer. Issue 1 (24th September 2013) Authors: Ciunci, Christine A.; Perini, Rodolfo F.; Avadhani, Anjali N.; Kang, Hyunseon C.; Sun, Weijing; Redlinger, Maryann; Harlacker, Kathleen; Flaherty, Keith T.; Giantonio, Bruce J.; Rosen, Mark A.; Divgi, Chaitanya R.; Song, Hee Kwon; Englander, Sarah; Troxel, Andrea; Schnall, Mitchell; O'Dwyer, Pete... Journal: Cancer Issue: Volume 120:Issue 1(2014) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer. Issue 1 (24th September 2013) Authors: Ciunci, Christine A.; Perini, Rodolfo F.; Avadhani, Anjali N.; Kang, Hyunseon C.; Sun, Weijing; Redlinger, Maryann; Harlacker, Kathleen; Flaherty, Keith T.; Giantonio, Bruce J.; Rosen, Mark A.; Divgi, Chaitanya R.; Song, Hee Kwon; Englander, Sarah; Troxel, Andrea; Schnall, Mitchell; O'Dwyer, Pete... Journal: Cancer Issue: Volume 120:Issue 1(2014) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗